<table id="SPLSERV-a6a7e7bb-2501-0abf-5840-5c249032799d" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<col width="27%"></col>
<col width="9%"></col>
<col width="8%"></col>
<col width="9%"></col>
<col width="8%"></col>
<col width="13%"></col>
<col width="15%"></col>
<col width="11%"></col>
<tbody>
<tr>
<td align="justify" colspan="1" stylecode=" Botrule Toprule" valign="top">
<br/>
</td>
<td align="center" colspan="2" stylecode=" Botrule Toprule" valign="top">Losartan Potassium Tablets<br/>
</td>
<td align="center" colspan="2" stylecode=" Botrule Toprule" valign="top">Atenolol<br/>
</td>
<td align="center" colspan="1" stylecode=" Botrule Toprule" valign="top">Risk Reduction*<br/>
</td>
<td align="center" colspan="1" stylecode=" Botrule Toprule" valign="top">95 % CI<br/>
</td>
<td align="center" colspan="1" stylecode=" Botrule Toprule" valign="top">p-Value<br/>
</td>
</tr>
<tr>
<td align="justify" stylecode=" Botrule Toprule" valign="top">
<br/>
</td>
<td align="center" stylecode=" Botrule Toprule" valign="top">N (%)<br/>
</td>
<td align="center" stylecode=" Botrule Toprule" valign="top">Rate<sup>†</sup>
<br/>
</td>
<td align="center" stylecode=" Botrule Toprule" valign="top">N (%)<br/>
</td>
<td align="center" stylecode=" Botrule Toprule" valign="top">Rate<sup>†</sup>
<br/>
</td>
<td align="justify" stylecode=" Botrule Toprule" valign="top">
<br/>
</td>
<td align="justify" stylecode=" Botrule Toprule" valign="top">
<br/>
</td>
<td align="justify" stylecode=" Botrule Toprule" valign="top">
<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Botrule Toprule" valign="top">Primary Composite Endpoint<br/>
</td>
<td align="center" stylecode=" Botrule Toprule" valign="top">508 (11)<br/>
</td>
<td align="center" stylecode=" Botrule Toprule" valign="top">23.8<br/>
</td>
<td align="center" stylecode=" Botrule Toprule" valign="top">588 (13)<br/>
</td>
<td align="center" stylecode=" Botrule Toprule" valign="top">27.9<br/>
</td>
<td align="center" stylecode=" Botrule Toprule" valign="top">13%<br/>
</td>
<td align="center" stylecode=" Botrule Toprule" valign="top">2% to 23%<br/>
</td>
<td align="center" stylecode=" Botrule Toprule" valign="top">0.021<br/>
</td>
</tr>
<tr>
<td align="justify" colspan="8" stylecode=" Botrule Toprule" valign="top">Components of  Primary Composite Endpoint (as a first event)<br/>
</td>
</tr>
<tr>
<td align="justify" stylecode=" Toprule" valign="top">Stroke (nonfatal<sup>‡</sup>)<br/>
</td>
<td align="center" stylecode=" Toprule" valign="top">209 (5)<br/>
</td>
<td align="justify" stylecode=" Toprule" valign="top">
<br/>
</td>
<td align="center" stylecode=" Toprule" valign="top">286 (6)<br/>
</td>
<td align="justify" stylecode=" Toprule" valign="top">
<br/>
</td>
<td align="justify" stylecode=" Toprule" valign="top">
<br/>
</td>
<td align="justify" stylecode=" Toprule" valign="top">
<br/>
</td>
<td align="justify" stylecode=" Toprule" valign="top">
<br/>
</td>
</tr>
<tr>
<td align="justify" valign="top">Myocardial infarction (nonfatal<sup>‡</sup>)<br/>
</td>
<td align="center" valign="top">174 (4)<br/>
</td>
<td align="justify" valign="top">
<br/>
</td>
<td align="center" valign="top">168 (4)<br/>
</td>
<td align="justify" valign="top">
<br/>
</td>
<td align="justify" valign="top">
<br/>
</td>
<td align="justify" valign="top">
<br/>
</td>
<td align="justify" valign="top">
<br/>
</td>
</tr>
<tr>
<td align="justify" stylecode=" Botrule" valign="top">Cardiovascular mortality<br/>
</td>
<td align="center" stylecode=" Botrule" valign="top">125 (3)<br/>
</td>
<td align="justify" stylecode=" Botrule" valign="top">
<br/>
</td>
<td align="center" stylecode=" Botrule" valign="top">134 (3)<br/>
</td>
<td align="justify" stylecode=" Botrule" valign="top">
<br/>
</td>
<td align="justify" stylecode=" Botrule" valign="top">
<br/>
</td>
<td align="justify" stylecode=" Botrule" valign="top">
<br/>
</td>
<td align="justify" stylecode=" Botrule" valign="top">
<br/>
</td>
</tr>
<tr>
<td align="justify" colspan="8" stylecode=" Botrule Toprule" valign="top">Secondary Endpoints (any time in study)<br/>
</td>
</tr>
<tr>
<td align="justify" stylecode=" Toprule" valign="top">Stroke (fatal/nonfatal)<br/>
</td>
<td align="center" stylecode=" Toprule" valign="top">232 (5)<br/>
</td>
<td align="center" stylecode=" Toprule" valign="top">10.8<br/>
</td>
<td align="center" stylecode=" Toprule" valign="top">309 (7)<br/>
</td>
<td align="center" stylecode=" Toprule" valign="top">14.5<br/>
</td>
<td align="center" stylecode=" Toprule" valign="top">25%<br/>
</td>
<td align="center" stylecode=" Toprule" valign="top">11% to 37%<br/>
</td>
<td align="center" stylecode=" Toprule" valign="top">0.001<br/>
</td>
</tr>
<tr>
<td align="justify" valign="top">Myocardial infarction (fatal/nonfatal)<br/>
</td>
<td align="center" valign="top">198 (4)<br/>
</td>
<td align="center" valign="top">9.2<br/>
</td>
<td align="center" valign="top">188 (4)<br/>
</td>
<td align="center" valign="top">8.7<br/>
</td>
<td align="center" valign="top">-7%<br/>
</td>
<td align="center" valign="top">-13% to 12%<br/>
</td>
<td align="center" valign="top">0.491<br/>
</td>
</tr>
<tr>
<td align="justify" valign="top">Cardiovascular mortality<br/>
</td>
<td align="center" valign="top">204 (4)<br/>
</td>
<td align="center" valign="top">9.2<br/>
</td>
<td align="center" valign="top">234 (5)<br/>
</td>
<td align="center" valign="top">10.6<br/>
</td>
<td align="center" valign="top">11%<br/>
</td>
<td align="center" valign="top">-7% to 27%<br/>
</td>
<td align="center" valign="top">0.206<br/>
</td>
</tr>
<tr>
<td align="left" valign="top">Due to CHD<br/>
</td>
<td align="center" valign="top">125 (3)<br/>
</td>
<td align="center" valign="top">5.6<br/>
</td>
<td align="center" valign="top">124(3)<br/>
</td>
<td align="center" valign="top">5.6<br/>
</td>
<td align="center" valign="top">-3%<br/>
</td>
<td align="center" valign="top">-32% to 20%<br/>
</td>
<td align="center" valign="top">0.839<br/>
</td>
</tr>
<tr>
<td align="left" valign="top">Due to Stroke<br/>
</td>
<td align="center" valign="top">40 (1)<br/>
</td>
<td align="center" valign="top">1.8<br/>
</td>
<td align="center" valign="top">62 (1)<br/>
</td>
<td align="center" valign="top">2.8<br/>
</td>
<td align="center" valign="top">35%<br/>
</td>
<td align="center" valign="top">4% to 67%<br/>
</td>
<td align="center" valign="top">0.032<br/>
</td>
</tr>
<tr>
<td align="left" stylecode=" Botrule" valign="top">Other<sup>§</sup>
<br/>
</td>
<td align="center" stylecode=" Botrule" valign="top">39 (1)<br/>
</td>
<td align="center" stylecode=" Botrule" valign="top">1.8<br/>
</td>
<td align="center" stylecode=" Botrule" valign="top">48 (1)<br/>
</td>
<td align="center" stylecode=" Botrule" valign="top">2.2<br/>
</td>
<td align="center" stylecode=" Botrule" valign="top">16%<br/>
</td>
<td align="center" stylecode=" Botrule" valign="top">-28% to 45%<br/>
</td>
<td align="center" stylecode=" Botrule" valign="top">0.411<br/>
</td>
</tr>
<tr>
<td align="justify" colspan="8" stylecode=" Toprule" valign="top">
<sup>*</sup> Adjusted for baseline Framingham risk score and level of electrocardiogram left ventricular hypertrophy<br/>
</td>
</tr>
<tr>
<td align="justify" colspan="8" valign="top">† Rate per 1000 patient-years of follow-up<br/>
</td>
</tr>
<tr>
<td align="justify" colspan="8" valign="top">‡ First report of an event, in some cases the patient died subsequently to the event reported<br/>
</td>
</tr>
<tr>
<td align="justify" colspan="8" valign="top">
<sup>§</sup> Death due to heart failure, non-coronary vascular disease, pulmonary embolism, or a cardiovascular cause other than stroke or     coronary heart disease<br/>
</td>
</tr>
</tbody>
</table>